Dr. Brett R. Neustater, MD

Dr. Neustater practices at Gastro Health in North Miami Beach, Florida.

Dr. Neustater's NPI, 1245212000, was assigned on November 17, 2005. Dr. Neustater graduated from University of Maryland School of Medicine - Baltimore in 1991. Dr. Neustater holds Florida license ME0063308.

Dr. Neustater's primary practice is Gastro Health, at 16855 Ne 2nd Ave, North Miami Beach, FL 33162 in Miami-Dade County. The practice phone is (305) 913-0666.

Dr. Neustater's primary practice is Gastro Health in North Miami Beach, Florida. Dr. Neustater is also affiliated with Mount Sinai Medical Center. The medical group on file is Gastro Health. Dmand AI also links Dr. Neustater to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Neustater practices, 4 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Neustater's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Neustater is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Neustater is licensed in Florida.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic indigestion, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, gastroduodenitis and gastroenteritis among the conditions Dr. Neustater treats.

CMS data shows 582 Medicare services from Dr. Neustater across 9 procedure codes in 2024, for 316 Medicare patients. Medicare paid $68,072 for them.

CMS counts 316 Medicare patients who saw Dr. Neustater in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high cholesterol, and 74% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.25, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Neustater's median patient age at 64, with 58% women.

In 2024, Dr. Neustater wrote 1,476 Medicare Part D claims for 714 patients. 63% of them were for generic drugs. CMS names the drug for 1,231 of them, across 31 drugs with 11 or more claims each, at $891,337 in total drug cost. In 2023, CMS named 1,264 claims across 32 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Neustater for performance year 2024, reported as part of a group. Dr. Neustater accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 90 procedures of colonoscopy by Dr. Neustater, more than 77% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Neustater. Dr. Neustater has published most often in Gastrointest Endosc. Dr. Neustater's most frequent co-authors are Jamie S. Barkin, MD, Robert I. Goldberg, MD and Neil H. Stollman, MD.

CMS Open Payments shows 618 general payments to Dr. Neustater from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 80% of the total. Allergan Inc. paid the most, $4,262.

Dmand AI lists 1 award for Dr. Neustater, most recently CMS Stage 1 2012 in 2011.

Dr. Neustater graduated from University of Maryland School of Medicine - Baltimore in 1991.

Dr. Neustater is in network with 10 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.